Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
Jinbing Xie, Zheyu Shen, Yasutaka Anraku, et al.
Biomaterials (2019) Vol. 224, pp. 119491-119491
Open Access | Times Cited: 440

Showing 26-50 of 440 citing articles:

Targeting pyroptosis as a preventive and therapeutic approach for stroke
Junpeng Long, Yang Sun, Shasha Liu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 57
An NIR-Driven Upconversion/C3N4/CoP Photocatalyst for Efficient Hydrogen Production by Inhibiting Electron–Hole Pair Recombination for Alzheimer’s Disease Therapy
Kezhen Ge, Zheng Li, Ali Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 3, pp. 2222-2234
Closed Access | Times Cited: 44
Biosensors integrated 3D organoid/organ-on-a-chip system: A real-time biomechanical, biophysical, and biochemical monitoring and characterization
Shan Liu, Shikha Kumari, Hongyi He, et al.
Biosensors and Bioelectronics (2023) Vol. 231, pp. 115285-115285
Closed Access | Times Cited: 44
Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy
Zhiqi Zhang, Xiaoxuan Xu, Jiawei Du, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 35
Role of pyroptosis in the pathogenesis of various neurological diseases
Abiola Oladapo, Thomas L. Jackson, Jueliet Menolascino, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 428-446
Closed Access | Times Cited: 29
An Engineered Nanoplatform with Tropism Toward Irradiated Glioblastoma Augments Its Radioimmunotherapy Efficacy
Zheng Wang, Fangman Chen, Yi Cao, et al.
Advanced Materials (2024) Vol. 36, Iss. 32
Closed Access | Times Cited: 22
Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases
Mitra Pirhaghi, Fatemeh Mamashli, Faezeh Moosavi-Movahedi, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 5, pp. 2097-2117
Closed Access | Times Cited: 17
Inorganic Nanoparticles and Blood-Brain Barrier Modulation: Advancing Targeted Neurological Therapies
Zahra Razavi, F. S. Razavi, Seyed Sina Alizadeh
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117357-117357
Closed Access | Times Cited: 6
Nanotechnology-Based Herbal Medicine: Preparation, Synthesis, and Applications in Food and Medicine
Farhang Hameed Awlqadr, Kithar Rasheed Majeed, Ammar B. Altemimi, et al.
Journal of Agriculture and Food Research (2025), pp. 101661-101661
Open Access | Times Cited: 5
Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Young‐Ju Jang, Seong-Jun Kang, Hyun Su Park, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Recent Advances in Nanoenzymes Based Therapies for Glioblastoma: Overcoming Barriers and Enhancing Targeted Treatment
Liyin Wang, Min Gu, Xiaoli Zhang, et al.
Advanced Science (2025)
Open Access | Times Cited: 4
Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment
Fatih Çiftçi, Ali Can Özarslan, İmran Cagri Kantarci, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 121-121
Open Access | Times Cited: 3
Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies
Jun Liao, Wenxiu He, Lisha Li, et al.
(2025), pp. 100016-100016
Open Access | Times Cited: 3
Macrophage membrane-camouflaged pure-drug nanomedicine for synergistic chemo- and interstitial photodynamic therapy against glioblastoma
Wei Cheng, Zhiran Duan, Han Chen, et al.
Acta Biomaterialia (2025)
Closed Access | Times Cited: 2
Lipid Nanocarriers as Precision Delivery Systems for Brain Tumors
Roshan Keshari, Mahima Dewani, Navneet Kaur, et al.
Bioconjugate Chemistry (2025)
Closed Access | Times Cited: 2
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Seyed Zachariah Moradi, Saeideh Momtaz, Zahra Bayrami, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 137
Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases
Yue Zhang, Han Yang, Daohe Wei, et al.
Exploration (2021) Vol. 1, Iss. 3
Open Access | Times Cited: 99
An update on actively targeted liposomes in advanced drug delivery to glioma
Solmaz Mojarad-Jabali, Masoud Farshbaf, Paul R. Walker, et al.
International Journal of Pharmaceutics (2021) Vol. 602, pp. 120645-120645
Closed Access | Times Cited: 92
Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration
Jinjin Wang, Qiankun Ni, Yufei Wang, et al.
Journal of Controlled Release (2020) Vol. 331, pp. 282-295
Closed Access | Times Cited: 87
Development of curcumin-loaded zein nanoparticles for transport across the blood–brain barrier and inhibition of glioblastoma cell growth
Huaiying Zhang, Winant L. van Os, Xiaobo Tian, et al.
Biomaterials Science (2021) Vol. 9, Iss. 21, pp. 7092-7103
Open Access | Times Cited: 82
Advances in drug delivery technology for the treatment of glioblastoma multiforme
Gi Doo, Taegyu Kang, Seungmin Baik, et al.
Journal of Controlled Release (2020) Vol. 328, pp. 350-367
Closed Access | Times Cited: 76
Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma
Zheyu Shen, Ting Liu, Zhèn Yáng, et al.
Biomaterials (2020) Vol. 235, pp. 119783-119783
Open Access | Times Cited: 71
The application of exosomes and Exosome-nanoparticle in treating brain disorders
Soodeh Salarpour, Mahmood Barani, Abbas Pardakhty, et al.
Journal of Molecular Liquids (2022) Vol. 350, pp. 118549-118549
Closed Access | Times Cited: 70
Blood–brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders
Hema Kumari Alajangi, Mandeep Kaur, Akanksha Sharma, et al.
Molecular Brain (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 70
Neisseria meningitidis Opca Protein/MnO2 Hybrid Nanoparticles for Overcoming the Blood–Brain Barrier to Treat Glioblastoma
Chengyuan Dong, Qian‐Xiao Huang, Han Cheng, et al.
Advanced Materials (2022) Vol. 34, Iss. 12
Closed Access | Times Cited: 67

Scroll to top